AR015257A1 - UNA COMPOSICION ACIDIFICADA Y EL USO DE DICHA COMPOSICION PARA LA MANUFACTURA DE UN MEDICAMENTO PARA EL TRATAMIENTO ToPICO DE CONDICIONES DE LAS UNAS Y DE LA PIEL - Google Patents

UNA COMPOSICION ACIDIFICADA Y EL USO DE DICHA COMPOSICION PARA LA MANUFACTURA DE UN MEDICAMENTO PARA EL TRATAMIENTO ToPICO DE CONDICIONES DE LAS UNAS Y DE LA PIEL

Info

Publication number
AR015257A1
AR015257A1 ARP990101430A ARP990101430A AR015257A1 AR 015257 A1 AR015257 A1 AR 015257A1 AR P990101430 A ARP990101430 A AR P990101430A AR P990101430 A ARP990101430 A AR P990101430A AR 015257 A1 AR015257 A1 AR 015257A1
Authority
AR
Argentina
Prior art keywords
composition
acidified
unique
manufacture
topical treatment
Prior art date
Application number
ARP990101430A
Other languages
English (en)
Original Assignee
Johnson & Johnson Consumer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson & Johnson Consumer filed Critical Johnson & Johnson Consumer
Publication of AR015257A1 publication Critical patent/AR015257A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q3/00—Manicure or pedicure preparations
    • A61Q3/02—Nail coatings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/20—Halogens; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A61K8/447—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof containing sulfur
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Birds (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Esta invencion se refiere a un método para el tratamiento topico de enfermedades de la piel y de las unas humanas, incluyendo infecciones fungales,infecciones bacterianas e infecciones psoriáticas. Además, esta invencion se refiere a un método para el tratamiento de la condicion general de las unashumanas incluyendo su fuerza, velocidad de crecimiento y apariencia. Más particularmente, la invencion se refiere a una composicion acidificada y amétodos para utilizar dicha composicion. Adicionalmente, la invencion se relaciona con una laca acidificada util en el tratamiento de las unas humanas yde la piel.
ARP990101430A 1998-03-31 1999-03-30 UNA COMPOSICION ACIDIFICADA Y EL USO DE DICHA COMPOSICION PARA LA MANUFACTURA DE UN MEDICAMENTO PARA EL TRATAMIENTO ToPICO DE CONDICIONES DE LAS UNAS Y DE LA PIEL AR015257A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8011698P 1998-03-31 1998-03-31
US09/265,284 US6231875B1 (en) 1998-03-31 1999-03-09 Acidified composition for topical treatment of nail and skin conditions

Publications (1)

Publication Number Publication Date
AR015257A1 true AR015257A1 (es) 2001-04-18

Family

ID=22155365

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP990101430A AR015257A1 (es) 1998-03-31 1999-03-30 UNA COMPOSICION ACIDIFICADA Y EL USO DE DICHA COMPOSICION PARA LA MANUFACTURA DE UN MEDICAMENTO PARA EL TRATAMIENTO ToPICO DE CONDICIONES DE LAS UNAS Y DE LA PIEL

Country Status (12)

Country Link
US (1) US6231875B1 (es)
EP (1) EP1067897A1 (es)
JP (1) JP2002509867A (es)
KR (1) KR20010042324A (es)
CN (1) CN1198563C (es)
AR (1) AR015257A1 (es)
AU (1) AU3211999A (es)
BR (1) BR9909324A (es)
CA (1) CA2326774A1 (es)
HK (1) HK1034189A1 (es)
TW (1) TWI225407B (es)
WO (1) WO1999049835A1 (es)

Families Citing this family (134)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9504265D0 (en) * 1995-03-03 1995-04-19 Medeva Plc Corticosteroid-containing pharmaceutical composition
DE19639817A1 (de) 1996-09-27 1998-04-02 Hoechst Ag Verwendung von 1-Hydroxy-2-pyridonen zur Behandlung von Hautinfektionen
DE19639816A1 (de) 1996-09-27 1998-04-02 Hoechst Ag Antimykotische Mittel mit hoher Wirkstofffreisetzung
US20040039030A1 (en) 1996-09-27 2004-02-26 Hoechst Akeengesellschaft Use of 1-hydroxy-2-pyridones for the treatment of seborrheic dermatitis
AUPO983897A0 (en) 1997-10-17 1997-11-06 Soltec Research Pty Ltd Topical antifungal composition
US20030235607A1 (en) * 1998-02-13 2003-12-25 Buck Carol J. Compositions and methods for inhibiting fungal growth and transference
AUPP310798A0 (en) 1998-04-22 1998-05-14 Soltec Research Pty Ltd Vehicle system for a composition comprising a piperidinopyrimidine derivative
CN1203184C (zh) * 1999-02-03 2005-05-25 拜奥盖尔药厂有限公司 经微生物学方法制备假单胞菌酸a抗生素的方法
DE19921794A1 (de) * 1999-05-11 2000-11-23 Hexal Ag Neue pharmazeutische Zusammensetzung
CA2291346A1 (en) * 1999-11-26 2001-05-26 Bernard Charles Sherman Antifungal solutions
US20090098065A1 (en) * 2000-01-11 2009-04-16 Avikam Harel Composition and methods for the treatment of skin disorders
MXPA02008072A (es) * 2000-02-16 2004-04-05 Bentley Pharmaceuticals Inc Composicion farmaceutica.
US6544555B2 (en) 2000-02-24 2003-04-08 Advancis Pharmaceutical Corp. Antibiotic product, use and formulation thereof
DE10011081A1 (de) * 2000-03-09 2001-09-13 Aventis Pharma Gmbh Antiinfektive Wirkstoffkombinationen und ihre Verwendung zur topischen Behandlung von Pilzerkrankungen der Fuß- und Fingernägel
US8257688B2 (en) * 2000-03-27 2012-09-04 Taro Pharmaceuticals Industries Controlled delivery system of antifungal and keratolytic agents for local treatment of fungal infections of the nail and surrounding tissues
US7074392B1 (en) 2000-03-27 2006-07-11 Taro Pharmaceutical Industries Limited Controllled delivery system of antifungal and keratolytic agents for local treatment of fungal infections
JP4814414B2 (ja) * 2000-05-26 2011-11-16 大正製薬株式会社 抗真菌液剤組成物
DE10035991A1 (de) * 2000-07-24 2002-02-14 Polichem Sa Nagellackzusammensetzung
JP4899139B2 (ja) * 2000-08-10 2012-03-21 株式会社ポーラファルマ 抗真菌医薬組成物
JP3838856B2 (ja) * 2000-09-11 2006-10-25 日本パーカライジング株式会社 アルミニウム含有金属材料用有機親水性処理剤及びその処理方法
US20040014848A1 (en) * 2000-09-11 2004-01-22 Kazuya Tanaka Organic Hydrophicizing agent for aluminiferous metals
DE10047486A1 (de) * 2000-09-26 2002-04-11 Bayer Ag Phenoxyphenyl Alkansulfonate
US20020068078A1 (en) 2000-10-13 2002-06-06 Rudnic Edward M. Antifungal product, use and formulation thereof
KR100435141B1 (ko) * 2000-12-28 2004-06-09 한미약품 주식회사 난용성 항진균제의 경구투여용 조성물 및 그의 제조 방법
GB0103046D0 (en) 2001-02-07 2001-03-21 Novartis Ag Organic Compounds
US6585963B1 (en) * 2001-02-15 2003-07-01 Watson Pharmaceuticals, Inc. Nail compositions and methods of administering same
US6878365B2 (en) * 2001-03-10 2005-04-12 James Edward Brehove Topical application for treating toenail fungus
US20090304603A1 (en) * 2001-06-15 2009-12-10 Cuticeuticals, Inc. Topical steroid spray with botanic seed oils
US20040022741A1 (en) * 2001-06-15 2004-02-05 Crutchfield Charles E. Topical steroid spray
AU2002345856A1 (en) * 2001-06-21 2003-01-08 Biogal Gyogyszergyar Rt Metabolic controlled fermentation process for pseudomonic acid production
US7244703B2 (en) * 2001-06-22 2007-07-17 Bentley Pharmaceuticals, Inc. Pharmaceutical compositions and methods for peptide treatment
KR100455216B1 (ko) * 2001-06-27 2004-11-09 한미약품 주식회사 난용성 항진균제의 경구투여용 조성물 및 이의 제조 방법
FR2830449B1 (fr) * 2001-10-05 2004-04-23 Fabre Pierre Dermo Cosmetique Utilisation du tazarotene pour la preparation d'un vernis a ongles pour le traitement et/ou la prevention du psoriasis et un vernis a ongles le contenant
AU2002364893A1 (en) * 2001-10-22 2003-06-17 University Of Mississippi Delivery of medicaments to the nail
US20040072810A1 (en) * 2001-11-07 2004-04-15 Besins International Belgique Pharmaceutical composition in the form of a gel or a solution based on dihydrotestosterone, process for preparing it and uses thereof
EP1565189A4 (en) * 2001-11-16 2006-11-02 Beatrice M Klysz ANTI-AGING SKIN CARE COMPOSITION AND ITS APPLICATIONS
WO2003045339A2 (en) * 2001-11-30 2003-06-05 Almell, Ltd. Coating for nail care having antimicrobial properties
HUP0600679A2 (en) 2001-12-28 2008-06-30 Biogal Gyogyszergyar Processes for preparing crystalline and amorphous mupirocin calcium and pharmaceutical compositions containing the same
US7198794B1 (en) 2002-02-22 2007-04-03 Lorri Riley Topical formulation for treating fingernails and toenails
CA2383296A1 (fr) * 2002-05-10 2003-11-10 Ginette Godbout Composition pour l'amelioration de la sante et de la structure des ongles, methode d'utilisation
WO2003105903A1 (ja) * 2002-06-18 2003-12-24 ポーラ化成工業株式会社 抗真菌医薬組成物
CN100381489C (zh) * 2002-06-25 2008-04-16 Mst有限公司 具有抗微生物或抗凝血性的聚合物树脂制剂及其制备方法
JP4081312B2 (ja) * 2002-06-28 2008-04-23 佐藤製薬株式会社 外用抗真菌剤
IL150907A (en) * 2002-07-25 2007-07-04 Stephan Cherkez Process for the preparation of stable amorphous calcium pseudomonate
GB2392446A (en) * 2002-09-02 2004-03-03 Reckitt Benckiser Nv Resin comprising water-soluble polymer and water-soluble filler
AU2003270273B2 (en) * 2002-09-05 2009-03-19 Galderma S.A. Solution for ungual application
US7374772B2 (en) * 2002-11-07 2008-05-20 Bommarito Alexander A Topical antifungal treatment
AU2003291810A1 (en) * 2002-11-18 2004-06-15 Teva Pharmaceutical Industries Ltd. A crystallization method for purification of calcipotriene
US7141237B2 (en) * 2003-01-24 2006-11-28 Connetics Australia Pty Ltd. Pharmaceutical foam
TW200501959A (en) * 2003-02-20 2005-01-16 Taisho Pharmaceutical Co Ltd Antifungal agents
US20040191194A1 (en) * 2003-03-28 2004-09-30 Carol Collins Nail composition
US7186416B2 (en) * 2003-05-28 2007-03-06 Stiefel Laboratories, Inc. Foamable pharmaceutical compositions and methods for treating a disorder
US20070099932A1 (en) * 2003-06-25 2007-05-03 Toshihiro Shirouzu External preparation for athlete's foot treatment
EP1648418A4 (en) 2003-07-21 2011-11-16 Middlebrook Pharmaceuticals Inc ANTIBIOTIC PRODUCT, ITS USE AND FORMULATION
CA2533292C (en) 2003-07-21 2013-12-31 Advancis Pharmaceutical Corporation Antibiotic product, use and formulation thereof
AU2004258949B2 (en) 2003-07-21 2011-02-10 Shionogi, Inc. Antibiotic product, use and formulation thereof
CA2535177A1 (en) 2003-08-11 2005-02-24 Advancis Pharmaceutical Corporation Robust pellet
EP1653924A4 (en) 2003-08-12 2009-09-09 Middlebrook Pharmaceuticals In ANTIBIOTICS, USE AND FORMULATION ASSOCIATED
CA2535780A1 (en) 2003-08-29 2005-03-17 Advancis Pharmaceuticals Corporation Antibiotic product, use and formulation thereof
CA2440172C (en) * 2003-09-05 2011-01-11 Bernard Charles Sherman Itraconazole solution
US8460710B2 (en) 2003-09-15 2013-06-11 Shionogi, Inc. Antibiotic product, use and formulation thereof
JP2005104924A (ja) * 2003-09-30 2005-04-21 Kobayashi Pharmaceut Co Ltd 外用医薬組成物
US20050095215A1 (en) * 2003-11-03 2005-05-05 Popp Karl F. Antimicrobial shampoo compositions
EP1706128B1 (en) * 2003-12-08 2010-07-21 CPEX Pharmaceuticals, Inc. Pharmaceutical compositions and methods for insulin treatment
ITMI20040312A1 (it) * 2004-02-24 2004-05-24 Euroderm R D C S P A Composizioni per il trattamento di patologie delle unghie e della pelle
WO2005108508A1 (en) * 2004-05-12 2005-11-17 Akzo Nobel Coatings International B.V. Antimicrobial acid-catalyzed coating compositions
CA2560984A1 (en) * 2004-06-01 2005-12-15 Teva Gyogyszergyar Zartkoruen Mukodo Reszvenytarsasag Process for preparation of amorphous form of a drug
US8741333B2 (en) 2004-06-07 2014-06-03 Nuvo Research Inc. Compositions and methods for treating dermatitis or psoriasis
US8741332B2 (en) 2004-06-07 2014-06-03 Nuvo Research Inc. Compositions and methods for dermally treating neuropathic pain
US8907153B2 (en) 2004-06-07 2014-12-09 Nuvo Research Inc. Adhesive peel-forming formulations for dermal delivery of drugs and methods of using the same
CA2570245A1 (en) * 2004-07-02 2006-01-12 Warner-Lambert Company Llc Compositions and methods for treating pathological infections
CA2572292A1 (en) 2004-07-02 2006-02-09 Advancis Pharmaceutical Corporation Tablet for pulsed delivery
US7842749B2 (en) * 2004-08-02 2010-11-30 Poly-Med, Inc. Tissue protecting spray-on copolymeric film composition
US20060068044A1 (en) * 2004-09-30 2006-03-30 Max Reynolds Antimicrobial compositions and applications therefore
US20100092398A1 (en) * 2004-09-30 2010-04-15 Max Reynolds Antimicrobial compositions and applications therefore
US20060078599A1 (en) * 2004-10-12 2006-04-13 Mathew Ebmeier Pharmaceutical composition applicable to body tissue
FR2884419B1 (fr) * 2005-04-19 2007-06-22 Galderma Sa Composition de type solution filmogene comprenant de la vitamine d ou un de ses derives et un corticosteroide, et son utilisation en dermatologie
WO2006111426A1 (en) * 2005-04-19 2006-10-26 Galderma S.A. Composition of film-forming solution type, comprising vitamin d or a derivative thereof and a corticosteroid, and use thereof in dermatology
AU2006245283B2 (en) * 2005-05-10 2012-11-01 Dermipsor Ltd. Compositions and methods for treating hyperproliferative epidermal diseases
US7793666B2 (en) * 2005-07-28 2010-09-14 Innovation Biomedical Devices, Inc. Apparatus and method for treatment of infected nail
JP5010125B2 (ja) * 2005-09-02 2012-08-29 有限会社日本健康科学研究センター 水虫治療用フィルム製剤
US20070071705A1 (en) * 2005-09-29 2007-03-29 De Oliveira Monica A M Topical anti-microbial compositions
FR2892023B1 (fr) * 2005-10-14 2009-09-25 Galderma Sa Composition pharmaceutique a base d'amorolfine et d'agent filmogene hydrosoluble pour application ungueale et peri-ungueale
US8778924B2 (en) 2006-12-04 2014-07-15 Shionogi Inc. Modified release amoxicillin products
US8357394B2 (en) 2005-12-08 2013-01-22 Shionogi Inc. Compositions and methods for improved efficacy of penicillin-type antibiotics
CN101378729B (zh) * 2005-12-14 2013-09-11 扎尔斯制药公司 治疗皮肤症状的制剂和方法
US20080299060A1 (en) * 2006-01-02 2008-12-04 Tlt Medical Ltd. Pharmaceutical Composition for the Treatment of Nail Diseases
AU2007273935B2 (en) 2006-03-31 2011-08-18 Stiefel Research Australia Pty Ltd Foamable suspension gel
WO2007113830A2 (en) * 2006-04-04 2007-10-11 Avner Shemer Kit for treating skin infection
US8299052B2 (en) 2006-05-05 2012-10-30 Shionogi Inc. Pharmaceutical compositions and methods for improved bacterial eradication
KR20090039833A (ko) * 2006-08-29 2009-04-22 테바 파마슈티컬 인더스트리즈 리미티드 비타민 ｄ 및 코르티코스테로이드를 포함하는 약학 조성물
US8727855B2 (en) * 2006-11-13 2014-05-20 Igt Three-dimensional paylines for gaming machines
US20080153122A1 (en) * 2006-12-21 2008-06-26 Susan Beth Cantor Method and system for enhancing self-treatment of onychomycosis
TWI433674B (zh) 2006-12-28 2014-04-11 Infinity Discovery Inc 環杷明（ｃｙｃｌｏｐａｍｉｎｅ）類似物類
EP1958613A1 (en) * 2007-02-15 2008-08-20 Polichem S.A. Dermal film-forming liquid formulations for drug release to skin
WO2009084020A2 (en) * 2007-10-18 2009-07-09 Glenmark Pharmaceuticals Limited Topical composition comprising halobetasol and salicylic acid
EP2222319A2 (de) * 2007-11-17 2010-09-01 Bayer Consumer Care AG Topische arzneimittel zur antimykotischen therapie
US20090175810A1 (en) * 2008-01-03 2009-07-09 Gareth Winckle Compositions and methods for treating diseases of the nail
US20090298805A1 (en) * 2008-06-03 2009-12-03 Polson George A Topical pyrithione compositions and methods for treatment of nail fungus
US20090324713A1 (en) * 2008-06-30 2009-12-31 Ulman John T Spray-on, non-woven fabric system and multilayer wound coverings
US20090324664A1 (en) * 2008-06-30 2009-12-31 Ulman John T Spray-on, non-woven fabric system and multilayer topical covering
WO2010011354A2 (en) * 2008-07-25 2010-01-28 Innovation Biomedical Devices, Inc. Enchanced trans-keratin drug delivery
WO2010014199A2 (en) * 2008-07-29 2010-02-04 The Board Of Regents Of The University Of Texas System Uses of morelloflavone
WO2010086727A1 (en) * 2009-01-30 2010-08-05 Galderma Pharma Sa Stable compositions for nail onychomycosis treatment
JP2012516320A (ja) * 2009-01-30 2012-07-19 イッスム リサーチ デベロプメント カンパニー オブ ザ ヘブライ ユニバーシティ オブ エルサレム リミテッド 爪および皮膚を処置するための組成物
US20100275942A1 (en) * 2009-05-01 2010-11-04 Barile Maria A Cosmetic nail covering
US20100292333A1 (en) * 2009-05-15 2010-11-18 bioCEPTA Corporation Compositions suitable for the topical treatment of fungal infections of the skin and nails
EP2434892B1 (en) * 2009-05-29 2015-08-19 Palau Pharma, S.A. Azole antifungal compositions
JP6141015B2 (ja) 2009-08-05 2017-06-07 インフィニティ ファーマスーティカルズ、インク． シクロパミン類似体の酵素によるアミノ基転移
KR20120038444A (ko) * 2009-08-13 2012-04-23 모베르그 데르마 아베 네일의 진균 감염 치료를 위한 조성물 및 방법
US8039494B1 (en) * 2010-07-08 2011-10-18 Dow Pharmaceutical Sciences, Inc. Compositions and methods for treating diseases of the nail
US9376447B2 (en) 2010-09-14 2016-06-28 Infinity Pharmaceuticals, Inc. Transfer hydrogenation of cyclopamine analogs
US20120082742A1 (en) * 2010-09-30 2012-04-05 Elorac, Ltd Method and compositions for treating cutaneous verrucae
US8481591B2 (en) 2010-11-01 2013-07-09 Stiefel Research Australia Pty. Ltd. Polymeric topical compositions
AU2010238566B2 (en) * 2010-11-01 2012-09-20 Stiefel Research Australia Pty Ltd Polymeric topical compositions
FR2976808B1 (fr) * 2011-06-22 2013-06-28 Urgo Lab Composition filmogene et son utilisation pour le traitement de l'herpes
FR2976806B1 (fr) * 2011-06-22 2013-06-28 Urgo Lab Composition topique filmogene et son utilisation pour le traitement des mycoses
KR101281470B1 (ko) * 2012-12-31 2013-07-03 전상문 피마자를 헥산으로 추출한 피마자유, 운데실렌산, 프로필알코올, 프로필렌글리콜 및 물을 함유하는 무좀 예방 또는 치료용 피부 외용제 조성물
US8697753B1 (en) 2013-02-07 2014-04-15 Polichem Sa Method of treating onychomycosis
AU2014329421B2 (en) 2013-10-03 2018-08-02 Dow Pharmaceutical Sciences, Inc. Stabilized efinaconazole compositions
EP3071295A4 (en) 2013-11-22 2017-05-31 Dow Pharmaceutical Sciences, Inc. Anti-infective methods, compositions, and devices
EP3091985B1 (en) 2014-01-10 2024-05-08 Manistee Therapeutics, Inc. Prostanglandins for topical use in the treatment of migraines.
US20160158393A1 (en) * 2014-02-21 2016-06-09 Avadim Technologies, Inc. Method for Improving Health Outcomes
LU92856B1 (en) 2014-02-21 2016-02-21 Avadim Technologies Inc Method for maintenance of urethral catheters
US10065029B2 (en) 2014-03-03 2018-09-04 Cook Medical Technologies Llc Mechanical dilator
JP2015212249A (ja) * 2014-05-05 2015-11-26 アナコール ファーマシューティカルズ，インコーポレイテッド 化合物および爪光沢剤
SG11201703184SA (en) 2014-10-21 2017-05-30 Hexima Ltd A method of treatment
JP2017534689A (ja) 2014-11-19 2017-11-24 アヴァディム・テクノロジーズ，インコーポレイテッド ざ瘡の予防および治療のための方法
CN107613987A (zh) * 2015-03-31 2018-01-19 雷迪博士实验室有限公司 糠酸莫米松的局部喷雾组合物
EP3302428A1 (en) 2015-06-04 2018-04-11 Pellepharm Inc. Topical formulations for delivery of hedgehog inhibitor compounds and use thereof
WO2017139497A1 (en) * 2016-02-11 2017-08-17 PellePharm, Inc. Hedgehog inhibitor for use in relief of and treatment of pruritus or itching
EP3432898A4 (en) * 2016-03-24 2020-03-11 Bioclenz PH LLC TREATMENT OF SKIN CONDITIONS AND DISEASES ASSOCIATED WITH MICROBIAL BIOLOGICAL FILMS
CN107115329A (zh) * 2017-04-28 2017-09-01 中国人民解放军第二军医大学第二附属医院 一种复方布替萘芬制剂及其应用
KR20240070423A (ko) 2022-11-11 2024-05-21 안재영 손톱 및 발톱용 화장품 조성물 및 이를 이용한 손톱 및 발톱 관리 방법

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR534810A (fr) 1921-04-19 1922-04-03 Dispositif de suspension à contrepoids et à poulies intérieures pour lampe électrique
DE1000567B (de) 1953-12-07 1957-01-10 Hans Fasching Erben K G Verfahren zur Erhaltung der pilzabtoetenden Wirkung von antimykotischen Substanzen bei Zugabe derselben zu nagelkeratin-aufweichenden Verbindungen (Thioglykolaten)
DE3544983A1 (de) 1985-12-19 1987-06-25 Hoechst Ag Antimykotisch wirksamer nagellack
HU200914B (en) 1987-03-09 1990-09-28 Horvath Gyoengyi Lengyelne Process for producing new medical dosage unit suitable for local treatment of fungus infection of nails
DE3720147A1 (de) 1987-06-16 1988-12-29 Hoechst Ag Antimykotisch wirksamer nagellack sowie verfahren zu dessen herstellung
US4956467A (en) 1988-04-01 1990-09-11 American Cyanamid Company Nucleophilic tertiary organophosphines
IL97012A0 (en) 1990-01-30 1992-03-29 Gist Brocades Nv Topical preparations for treating human nails
IL94806A0 (en) 1990-06-20 1991-04-15 Ernest Bar On Pharmaceutical preparation containing thiol derivatives together with other active compounds
IT1249047B (it) 1991-02-21 1995-02-11 Zambon Spa Composizione farmaceutica per il trattamento della cataratta
FR2689008A1 (fr) 1992-03-31 1993-10-01 Louis Benelli Compositions efficaces notamment contre la chute des cheveux et pour favoriser leur régénération ainsi que celle des ongles.
WO1994016991A1 (en) 1993-01-29 1994-08-04 Schering-Plough Healthcare Products, Inc. Stable sulfide compositions, uses, and process for preparation thereof
IL105600A (en) 1993-05-04 1999-12-31 Allon Blank Pharmaceutical and cosmetic compositions with increased rate of transdermal penetration and antioxidation protection against degradation containing derivatives of thioglycolic and mercaptopropionic acids some such novel compounds and their use
US5461068A (en) * 1993-09-29 1995-10-24 Corwood Laboratories, Inc. Imidazole derivative tincture and method of manufacture
US5958458A (en) * 1994-06-15 1999-09-28 Dumex-Alpharma A/S Pharmaceutical multiple unit particulate formulation in the form of coated cores
US5696164A (en) 1994-12-22 1997-12-09 Johnson & Johnson Consumer Products, Inc. Antifungal treatment of nails
DE19604190A1 (de) 1996-02-06 1997-08-07 Hoechst Ag Nagelwachstumsfördernde Zubereitungen
US5993787A (en) * 1996-09-13 1999-11-30 Johnson & Johnson Consumer Products, Inc. Composition base for topical therapeutic and cosmetic preparations

Also Published As

Publication number Publication date
HK1034189A1 (en) 2001-10-19
AU3211999A (en) 1999-10-18
CN1295456A (zh) 2001-05-16
TWI225407B (en) 2004-12-21
KR20010042324A (ko) 2001-05-25
CN1198563C (zh) 2005-04-27
BR9909324A (pt) 2000-12-05
US6231875B1 (en) 2001-05-15
JP2002509867A (ja) 2002-04-02
CA2326774A1 (en) 1999-10-07
EP1067897A1 (en) 2001-01-17
WO1999049835A1 (en) 1999-10-07

Similar Documents

Publication Publication Date Title
AR015257A1 (es) UNA COMPOSICION ACIDIFICADA Y EL USO DE DICHA COMPOSICION PARA LA MANUFACTURA DE UN MEDICAMENTO PARA EL TRATAMIENTO ToPICO DE CONDICIONES DE LAS UNAS Y DE LA PIEL
TR200101307T2 (tr) Antranilik asit amidler ve ilaç olarak kullanılmaları.
EE9800301A (et) Bensofenooni ühendid, meetodid nende valmistamiseks, kompositsioon ja meetodid seene või taime seenhaiguse tõrjeks
ATE478670T1 (de) Rezeptor-selektive cannabimimetische aminoalkylindole
WO2001045679A3 (de) Verwendung von chemotherapeutika zur topischen behandlung
BR0204596A (pt) Composição tópica, e, métodos para melhorar a aparência estética da pele, para intensificar a eficácia terapêutica de uma composição tópica para a pele, unha, lábios e/ou cabelo e para intensificar a produção de um constituinte de célula de planta predeterminada
EE200300033A (et) Tsüklopentanoindoolid, nende kasutamine ravimi valmistamiseks ning neid sisaldav farmatseutiline kompositsioon
IL178072A0 (en) Use of monoesters of probucol or a pharmaceutically acceptable salt thereof for preparing medicaments for the treatment of cardiovascular disease
HN1999000124A (es) Derivados de pirazol substituido.
DE60138549D1 (de) Topische gel-abgabesysteme zur behandlung von hauterkrankungen
UY26372A1 (es) "imidazo-3-il-aminas bicíclicas procedimiento para su preparación y medicamentos que las contienen "
FI970747A (fi) Yhdistelmävalmiste käytettäväksi immunologisissa sairauksissa
ES2127490T3 (es) Utilizacion de un aceite rico en acido petroselenico como agente hidratante.
HUP9602498A2 (hu) Antimikrobiális hatású gyógyászati készítmények
DE60216077D1 (de) Topisches produkt mit visuellem indikator
ES2124983T3 (es) Utilizacion de un antagonista de substancia p para el tratamiento de las manchas rojas cutaneas de origen neurogeno.
BG105275A (en) Tan-1057 derivatives
CA2351947A1 (en) Hyperforin as cytostatic agent and hyperforin ointment or cream as application form
HUP9902415A2 (hu) Azonnal felszabaduló szilárd beadási formák és eljárás azok előállítására
ITMI922742A0 (it) Composti ad attivita' terapeutica utili per il trattamento di malattieconnesse ad una carenza di glutatione, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono.
ES2156446T3 (es) Formulacion farmaceutica semisolida que contiene dexketoprofeno trometanol.
IE870577L (en) Topical amide preparation
DOP2001000140A (es) Aril y heteroarilsulfonatos
SV2003001061A (es) Nuevos heterociclos 3 ref.lea 35361-sv
MX9301879A (es) Medicamento para el tratamiento de la inflamacion de las vias respiratorias

Legal Events

Date Code Title Description
FB Suspension of granting procedure